Compounds > hydroxyl radical
Page last updated: 2024-09-04

hydroxyl radical and razoxane

hydroxyl radical has been researched along with razoxane in 5 studies

Compound Research Comparison

Studies
(hydroxyl radical)		Trials
(hydroxyl radical)		Recent Studies (post-2010)
(hydroxyl radical)		Studies
(razoxane)		Trials
(razoxane)		Recent Studies (post-2010) (razoxane)
10,147263,65782411556

Protein Interaction Comparison

ProteinTaxonomyhydroxyl radical (IC50)razoxane (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 23.19

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Myers, CE; Politi, PM; Rajagopalan, S; Sinha, BK1
Hasinoff, BB1
Hasinoff, BB; Malisza, KL1
Buss, JL; Hasinoff, BB1
Thomas, C; Vile, GF; Winterbourn, CC1

Other Studies

5 other study(ies) available for hydroxyl radical and razoxane

ArticleYear
Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity.
    Cancer research, 1988, Sep-01, Volume: 48, Issue:17

    Topics: Animals; Doxorubicin; Free Radicals; Heart; Hydroxides; Hydroxyl Radical; Male; Myocardium; Perfusion; Rats; Rats, Inbred Strains; Razoxane; Superoxide Dismutase

1988
NADPH-cytochrome-P450 reductase promotes hydroxyl radical production by the iron complex of ADR-925, the hydrolysis product of ICRF-187 (dexrazoxane).
    Free radical research, 1995, Volume: 22, Issue:4

    Topics: Animals; Catalase; Chelating Agents; Edetic Acid; Electron Spin Resonance Spectroscopy; Ethylenediamines; Glycine; Hydroxyl Radical; Iron Chelating Agents; Models, Chemical; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Rats; Razoxane; Spectrophotometry, Ultraviolet

1995
Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicals.
    Archives of biochemistry and biophysics, 1995, Feb-01, Volume: 316, Issue:2

    Topics: Aerobiosis; Antibiotics, Antineoplastic; Antioxidants; Chelating Agents; Doxorubicin; Electron Spin Resonance Spectroscopy; Ethylenediamines; Ferric Compounds; Ferrous Compounds; Glycine; Heart; Hydrolysis; Hydroxyl Radical; Mitoxantrone; Models, Chemical; Oxidation-Reduction; Razoxane

1995
Ferrous ion strongly promotes the ring opening of the hydrolysis intermediates of the antioxidant cardioprotective agent dexrazoxane (ICRF-187).
    Archives of biochemistry and biophysics, 1995, Feb-20, Volume: 317, Issue:1

    Topics: Chromatography, High Pressure Liquid; Ferric Compounds; Ferrous Compounds; Hydrogen-Ion Concentration; Hydrolysis; Hydroxyl Radical; Models, Molecular; Razoxane; Spectrophotometry

1995
The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction.
    Biochemical pharmacology, 1993, May-25, Volume: 45, Issue:10

    Topics: Ascorbic Acid; Chelating Agents; Deoxyribose; Dimethyl Sulfoxide; Doxorubicin; Edetic Acid; Ethylenediamines; Ferric Compounds; Glycine; Hydrogen Peroxide; Hydrolysis; Hydroxides; Hydroxyl Radical; Iron; Kinetics; Oxidation-Reduction; Paraquat; Razoxane; Superoxides; Thiobarbituric Acid Reactive Substances; Xanthine Oxidase

1993